The FDA maintains strict approval timelines that pharmaceutical companies must follow before generic competition becomes possible
The article lists pre-existing kidney disease, liver cirrhosis, thyroid nodules, and a personal or family history of medullary thyroid cancer as reasons for more frequent biomarker checks, adding that some of these patients may not be candidates for therapy at all
Following dilutions of antihuman primary antibodies in PBS were applied overnight at 4 C: Nestin (Millipore, MAB5326, 1:200), SOX2 (Abcam, ab97959, 1:200), Doublecortin (Cell Signaling, 4604S, 1:200), MAP2 (Millipore, MAB3418, 1:200), PSA-NCAM (Millipore, MAB5324, 1:200), PSD95 (Abcam, ab18258, 1:200) Tubulin, beta 3 (Millipore, MAB1637, 1:200)
R., Schuitema, I., Sander, J
Therefore, understanding the limitations of peptide storage in the fridge is crucial for maintaining their integrity
With so many changes ahead, companies must stay agile, monitoring and adjusting their GLP-1 coverage strategies as the market evolves